Cook Medical and Surmodics reach distribution agreement for two new vascular products

Cook Medical and Surmodics have announced an agreement in which Cook Medical will distribute two new Surmodics products, hydrophilic percutaneous transluminal angioplasty (PTA) balloon catheters that can be used over 0.014-inch and a 0.018-inch wire guides. “We have had a long relationship with Surmodics, utilising its innovative surface modification technology with many of our [...]

2020-05-11T15:49:16+00:00May 11th, 2020|Tags: , , |

Abiomed acquires novel ECMO developer Breethe

Abiomed (maker of the Impella heart pump) has acquired Breethe, developer of a novel extracorporeal membrane oxygenation (ECMO) system. A press release reports that the acquisition will complement and expand Abiomed’s product portfolio to more comprehensively serve the needs of patients whose lungs can no longer provide sufficient oxygenation. Such patients include those with cardiogenic [...]

2020-05-01T13:18:09+00:00May 1st, 2020|Tags: , , , |

Artio Medical appoints Nathaniel Hagedorn to board of directors

Nathaniel Hagedorn Artio Medical has announced the appointment of entrepreneur and businessman Nathaniel Hagedorn to its board of directors. As the founder and CEO of NorthPoint Development, Hagedorn has raised over $6.5B in capital and brings nearly two decades of experience in accessing new markets and scaling new business opportunities. Hagedorn founded [...]

2020-05-01T12:25:25+00:00May 1st, 2020|Tags: , , |

Boston Scientific reveals CE mark for Acurate neo 2 in Q1 financial results report

Acurate neo (first generation) Boston Scientific, according to a press release announcing the company’s Q1 2020 financial results, has received the CE mark for its Acurate neo2 aortic valve system. The press release reports that the transcatheter aortic valve implantation (TAVI) system builds on the clinical performance of the original Acurate neo [...]

Cardiovascular robotics company secures €40 million series C financing round

Robocath, which designs, develops and commercialises cardiovascular robotic systems for the treatment of vascular diseases, has secured €40 million ($43M) in a series C round of financing. A press release reports that this was led by MicroPort Scientific Corporation, with participation from institutional investors (Zhejiang Silk Road Fund, Luxembourg CLIIF managed under TUS-Holdings, CS [...]

2020-05-01T10:24:07+00:00May 1st, 2020|Tags: , , |

Proximo Medical named as commercialisation partner for Elucid Bioimaging

Elucid Bioimaging Proximo Medical has announced a partnership with Elucid Bioimaging, a developer of diagnostic image analysis software used to assist in the detection and treatment of myocardial infarction and stroke. A press release states that Elucid Bioimaging’s signature technology, vascuCAP, is the only Food and Drug Administration (FDA)-cleared, histologically-validated software for [...]

2020-04-22T12:29:23+00:00April 22nd, 2020|Tags: , , |

MolecuLight announces strategic alliance with Tissue Analytics

i:X MolecuLight has announced the integration of its MolecuLight i:X device with Tissue Analytics’ interconnected platform for seamless integration with leading electronic medical record (EMR)/electronic health record (EHR) platforms. According to a press release, Tissue Analytics is an artificial intelligence (AI)-powered cloud-based software solution that allows providers to monitor and automatically measure [...]

2020-04-16T15:33:00+00:00April 16th, 2020|Tags: , , |

OrthoPediatrics buys ApiFix Ltd, developer of FDA-approved non-fusion scoliosis technology

OrthoPediatrics has acquired ApiFix, including its minimally invasive deformity correction (MID-C) system for non-fusion treatment of progressive adolescent idiopathic scoliosis, for 934,768 shares of OrthoPediatrics common stock and US$2 million in cash paid at closing, plus milestone payments and an earnout over a period of four years. A press release reports that ApiFix is [...]

2020-04-06T10:07:53+00:00April 6th, 2020|Tags: , , , |

COVID-19: Boston Scientific takes steps to mitigate impact of pandemic

Boston Scientific has revealed that its assuming the Q2 2020 impact of COVID-19 will be more significant than that of Q1 2020. As a result, the company is “taking proactive steps to reduce costs and be in a strong position to support customers and patients when healthcare systems begin to recover, and elective procedures [...]

2020-04-02T16:24:12+00:00April 2nd, 2020|Tags: , , |

Artio Medical Closes $8.8 million of additional dinancing

Artio Medical, a medical device company developing innovative products for the peripheral vascular and neurovascular markets, has closed an additional $8.8 million in Series A financing, bringing the total capital raised to date to more than $20 million. The additional funds will help Artio obtain 510(k) marketing clearance from the FDA to market the [...]

2020-04-01T16:06:12+00:00April 1st, 2020|Tags: , |

ATEC agrees to acquire EOS imaging

EOSedge Alphatec Holdings (ATEC) has announced that it has entered into an agreement to acquire EOS imaging for a purchase price of up to US$88 million, plus debt retirement of US$33.9 million, in a combination of cash and equity. EOS imaging is specialist in orthopaedic medical imaging and software solutions. The EOS technology [...]

2020-03-05T11:09:44+00:00March 5th, 2020|Tags: , , , |

Medtronic acquires UK company Digital Surgery

Medtronic has announced its acquisition of Digital Surgery, which is a privately-held pioneer in surgical artificial intelligence (AI), data and analytics, and digital education and training. A press release says that the acquisition will strengthen the Medtronic robotic-assisted surgery platform and has applicability for the Medtronic broader portfolio. The terms of the agreement have [...]

2020-02-17T13:49:00+00:00February 17th, 2020|Tags: , , , |

Rexgenero appoints Huw Jones as a non-executive director

Huw Jones Rexgenero has announced that Huw Jones has joined the company’s board as a non-executive director, and will chair the company’s remuneration committee. This follows the recent appointment of David Horn Solomon as chairman of Rexgenero’s Board. Huw is currently CEO of Chronos Therapeutics Limited (Chronos), a spin out from the [...]

2020-02-17T13:39:13+00:00February 17th, 2020|Tags: , |